What and When to Submit to the IRB?

What and When to Submit to the IRB?

By Elizabeth Gargill on Wed, Apr 29, 2020 | 1 min read

Insights from Advarra on Managing Changes to Patient Enrollment & Engagement due to COVID-19

Get an IRB's perspective on managing clinical trial enrollment modifications due to COVID-19 by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra.

 

 

Learn how to navigate changes with insight on reimbursement, patient travel, site closures, medication delivery, remote informed consent, and more! Understand recommended guidance on what and when to report to an IRB.

Featuring:

  • Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra
  • Rob Laurens, Principal, Quality Assurance, BBK Worldwide

 

 

Topics: Patient Engagement, COVID-19, Clinical Trial Enrollment, Institutional Review Board, Rob Laurens, IRB